109 related articles for article (PubMed ID: 19665041)
41. Effect of recombinant human fibroblast interferon and mezerein on growth, differentiation, immune interferon binding and tumor associated antigen expression in human melanoma cells.
Fisher PB; Hermo H; Solowey WE; Dietrich MC; Edwalds GM; Weinstein IB; Langer JA; Pestka S; Giacomini P; Kusama M
Anticancer Res; 1986; 6(4):765-74. PubMed ID: 2944474
[TBL] [Abstract][Full Text] [Related]
42. Effects of retinoic acid combined with irradiation on the expression of major histocompatibility complex molecules and adhesion/costimulation molecules ICAM-1 in human cervical cancer.
Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Hiserodt JC; Pecorelli S; Parham GP
Gynecol Oncol; 1998 Aug; 70(2):195-201. PubMed ID: 9740690
[TBL] [Abstract][Full Text] [Related]
43. The role of HLA-G in gastrointestinal inflammatory disease and malignancy.
Downs-Kelly E; Schade AE; Hansel DE
Semin Cancer Biol; 2007 Dec; 17(6):451-8. PubMed ID: 17716911
[TBL] [Abstract][Full Text] [Related]
44. HLA-G and its relation to proliferation index in detection and monitoring breast cancer patients.
Sayed D; Badr G; Maximous D; Mikhail NN; Abu-Tarboush F; Alhazza IM
Tissue Antigens; 2010 Jan; 75(1):40-7. PubMed ID: 20196818
[TBL] [Abstract][Full Text] [Related]
45. Possible role of human leukocyte antigen-G molecules in human oocyte/embryo secretome.
Rizzo R; Stignani M; Melchiorri L; Baricordi OR
Hum Immunol; 2009 Dec; 70(12):970-5. PubMed ID: 19654031
[TBL] [Abstract][Full Text] [Related]
46. A subclass of soluble HLA-G1 modulates the release of cytokines from mononuclear cells present in the decidua additively to membrane-bound HLA-G1.
Kanai T; Fujii T; Kozuma S; Miki A; Yamashita T; Hyodo H; Unno N; Yoshida S; Taketani Y
J Reprod Immunol; 2003 Dec; 60(2):85-96. PubMed ID: 14638437
[TBL] [Abstract][Full Text] [Related]
47. Full-length HLA-G1 and truncated HLA-G3 differentially increase HLA-E surface localization.
Teklemariam T; Zhao L; Hantash BM
Hum Immunol; 2012 Sep; 73(9):898-905. PubMed ID: 22732094
[TBL] [Abstract][Full Text] [Related]
48. Production of immune-modulatory nonclassical molecules HLA-G and HLA-E by tumor infiltrating ameboid microglia/macrophages in glioblastomas: a role in innate immunity?
Kren L; Muckova K; Lzicarova E; Sova M; Vybihal V; Svoboda T; Fadrus P; Smrcka M; Slaby O; Lakomy R; Vanhara P; Krenova Z; Michalek J
J Neuroimmunol; 2010 Mar; 220(1-2):131-5. PubMed ID: 20167379
[TBL] [Abstract][Full Text] [Related]
49. Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-kappaB inducers.
Zidi I; Guillard C; Marcou C; Krawice-Radanne I; Sangrouber D; Rouas-Freiss N; Carosella ED; Moreau P
Cell Mol Life Sci; 2006 Nov; 63(22):2669-81. PubMed ID: 17072500
[TBL] [Abstract][Full Text] [Related]
50. Exosomes bearing HLA-G are released by melanoma cells.
Riteau B; Faure F; Menier C; Viel S; Carosella ED; Amigorena S; Rouas-Freiss N
Hum Immunol; 2003 Nov; 64(11):1064-72. PubMed ID: 14602237
[TBL] [Abstract][Full Text] [Related]
51. Soluble HLA-G: Are they clinically relevant?
Pistoia V; Morandi F; Wang X; Ferrone S
Semin Cancer Biol; 2007 Dec; 17(6):469-79. PubMed ID: 17825579
[TBL] [Abstract][Full Text] [Related]
52. Detection of 3-nitrotyrosine-modified human leukocyte antigen-G in biological fluids.
Díaz-Lagares A; Alegre E; Gonzalez A
Hum Immunol; 2009 Dec; 70(12):976-80. PubMed ID: 19651177
[TBL] [Abstract][Full Text] [Related]
53. Hypoxia does not reduce HLA-G expression on extravillous cytotrophoblasts.
Nagamatsu T; Fujii T; Yamashita T; Miki A; Kanai T; Kusumi M; Osuga Y; Kozuma S; Taketani Y
J Reprod Immunol; 2004 Oct; 63(2):85-95. PubMed ID: 15380940
[TBL] [Abstract][Full Text] [Related]
54. Human leukocyte antigen-G (HLA-G) as a marker for diagnosis, prognosis and tumor immune escape in human malignancies.
Yie SM; Hu Z
Histol Histopathol; 2011 Mar; 26(3):409-20. PubMed ID: 21210353
[TBL] [Abstract][Full Text] [Related]
55. Linking two immuno-suppressive molecules: indoleamine 2,3 dioxygenase can modify HLA-G cell-surface expression.
González-Hernandez A; LeMaoult J; Lopez A; Alegre E; Caumartin J; Le Rond S; Daouya M; Moreau P; Carosella ED
Biol Reprod; 2005 Sep; 73(3):571-8. PubMed ID: 15878889
[TBL] [Abstract][Full Text] [Related]
56. Application of human leukocyte antigen-G expression in the diagnosis of human cancer.
Shih IeM
Hum Immunol; 2007 Apr; 68(4):272-6. PubMed ID: 17400063
[TBL] [Abstract][Full Text] [Related]
57. Expression of human leucocyte antigen-G primarily targets affected skin of patients with psoriasis.
Cardili RN; Alves TG; Freitas JC; Soares CP; Mendes-Junior CT; Soares EG; Donadi EA; Silva-Souza C
Br J Dermatol; 2010 Oct; 163(4):769-75. PubMed ID: 20560954
[TBL] [Abstract][Full Text] [Related]
58. Modulation of HLA-G expression in human neural cells after neurotropic viral infections.
Lafon M; Prehaud C; Megret F; Lafage M; Mouillot G; Roa M; Moreau P; Rouas-Freiss N; Carosella ED
J Virol; 2005 Dec; 79(24):15226-37. PubMed ID: 16306594
[TBL] [Abstract][Full Text] [Related]
59. Immunomodulation of classical and non-classical HLA molecules by ionizing radiation.
Gallegos CE; Michelin S; Dubner D; Carosella ED
Cell Immunol; 2016 May; 303():16-23. PubMed ID: 27113815
[TBL] [Abstract][Full Text] [Related]
60. Non-classic sHLA class I in human oocyte culture medium.
Menicucci A; Noci I; Fuzzi B; Criscuoli L; Scarselli G; Baricordi O; Mattiuz PL
Hum Immunol; 1999 Nov; 60(11):1054-7. PubMed ID: 10600002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
